Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | ||||||
{[ item.p_purity ]} | {[ item.pr_size ]} | Inquiry |
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,1,item.pr_is_large_size_no_price) ]} |
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate,item.pr_is_large_size_no_price) ]} | {[ item.pr_usastock ]} | in stock Inquiry - | {[ item.pr_chinastock ]} | {[ item.pr_remark ]} in stock 1-2 weeks - Inquiry - | Login | Inquiry |
Please Login or Create an Account to: See VIP prices and availability
CAS No. : | 1129634-44-1 | MDL No. : | MFCD11099673 |
Formula : | C12H19NO4 | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | - |
M.W : | 241.28 | Pubchem ID : | - |
Synonyms : |
|
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H302-H315-H319-H335 | Packing Group: | N/A |
GHS Pictogram: |
![]() |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
44% | The solution of (S)-5-(tert-butoxycarbonyl)-5-azaspiro[2.4]heptane-6-carboxylicacid (2.0 g, 8.5 mmol) and NMI (2.1 g, 25.5 mmol) in DMF (20 mL), cooled to 0 oC,was added by MsCl (978 mg, 8.5 mmol) dropwise, and kept stirring for 15min. Then <strong>[66521-66-2]4-(pyridin-3-yl)pyrimidin-2-amine</strong> (980 mg, 5.7 mmol) was added,followed by addition of lithium chloride (721 mg, 17.0 mmol). The reaction wasstirred at rt and monitored by TLC. After 48 h, the mixture was diluted by EA,washed by 10% citric acid, and extracted by EA (2x50 mL). The combined organiclayers were washed by saturated Na2CO3 solution and brine.Concentration under reduced pressure gave the crude, which was purified bysilica gel (DCM/MeOH = 100/1 to 30/1) to get the pure product (1.0 g, 44%yield).1H NMR(400 MHz, CDCl3) (two rotomers were observed) delta 9.98 (brs, 0.5H),9.28 (d, J = 2.0 Hz, 1H), 9.06 (brs, 0.5H),8.83-8.70 (m, 2H), 8.42 (d, J = 8.0Hz, 1H), 7.56-7.40 (m, 2H), 4.96-4.60 (m, 1H), 3.65-3.50 (m, 1H), 3.45-3.10 m, 1H),2.50-2.25 (m, 1H), 2.20-2.05 (m, 1H), 1.51 (s, 9H), 0.78-0.54 (s, 4H). | |
44% | (S)-5-(tert-butoxycarbonyl)-5-azaspiro[2.4]heptane-6-carboxylic acid (2.0 g, 8.5 mmol) was dissolved in DMF (20 mL), followed by the addition of NMI (2.1 g, 25.5 mmol). The mixture was cooled to 0 C, into which MsCl (978 mg, 8.5 mmol) was added dropwise. The mixture was stirred for 15 min. Then 4-(3-pyridyl)pyrimidin-2-amine (980 mg, 5.7 mmol) and lithium chloride (721 mg, 17.0 mmol) were added. After reacting at room temperature for 48 hours under stirring, the reaction mixture was diluted with ethyl acetate, and washed with 10% citric acid aqueous solution. The aqueous phase was extracted with ethyl acetate (2x50 mL). The organic phase was washed with saturated sodium carbonate and sodium chloride. After concentrating under reduced pressure, pure product (1.0g, 44% yield) was obtained by the purification of the crude product through silica gel column (DCM/MeOH = 100/1-30/1). 1H NMR (400 MHz, CDCl3) (two rotomers were observed) delta 9.98 (brs, 0.5H), 9.28 (d, J = 2.0 Hz, 1H), 9.06 (brs, 0.5H), 8.83-8.70 (m, 2H), 8.42 (d, J = 8.0 Hz, 1H), 7.56-7.40 (m, 2H), 4.96-4.60 (m, 1H), 3.65-3.50 (m, 1H), 3.45-3.10 m, 1H), 2.50-2.25 (m, 1H), 2.20-2.05 (m, 1H), 1.51 (s, 9H), 0.78-0.54 (s, 4H). |
A101613[ 1441673-92-2 ]
Potassium (S)-5-(tert-butoxycarbonyl)-5-azaspiro[2.4]heptane-6-carboxylate
Reason: Free-Salt
[ 1441673-92-2 ]
Potassium (S)-5-(tert-butoxycarbonyl)-5-azaspiro[2.4]heptane-6-carboxylate
Similarity: 0.98
[ 197142-34-0 ]
(1R,3S,5R)-2-(tert-Butoxycarbonyl)-2-azabicyclo[3.1.0]hexane-3-carboxylic acid
Similarity: 0.98
[ 1217525-04-6 ]
(2R)-1-(tert-Butoxycarbonyl)octahydro-1H-indole-2-carboxylic acid
Similarity: 0.98
[ 291775-59-2 ]
(1R,3S,4S)-2-(tert-Butoxycarbonyl)-2-azabicyclo[2.2.1]heptane-3-carboxylic acid
Similarity: 0.95
[ 98303-20-9 ]
1-(tert-Butoxycarbonyl)piperidine-2-carboxylic acid
Similarity: 0.92
[ 197142-34-0 ]
(1R,3S,5R)-2-(tert-Butoxycarbonyl)-2-azabicyclo[3.1.0]hexane-3-carboxylic acid
Similarity: 0.98
[ 1217525-04-6 ]
(2R)-1-(tert-Butoxycarbonyl)octahydro-1H-indole-2-carboxylic acid
Similarity: 0.98
[ 291775-59-2 ]
(1R,3S,4S)-2-(tert-Butoxycarbonyl)-2-azabicyclo[2.2.1]heptane-3-carboxylic acid
Similarity: 0.95
[ 98303-20-9 ]
1-(tert-Butoxycarbonyl)piperidine-2-carboxylic acid
Similarity: 0.92
[ 159749-28-7 ]
1-(tert-Butoxycarbonyl)azetidine-2-carboxylic acid
Similarity: 0.90
[ 1441673-92-2 ]
Potassium (S)-5-(tert-butoxycarbonyl)-5-azaspiro[2.4]heptane-6-carboxylate
Similarity: 0.98
[ 175526-97-3 ]
1-Boc-3-Pyrrolidineacetic acid
Similarity: 0.84
[ 204688-61-9 ]
(S)-2-(1-(tert-Butoxycarbonyl)pyrrolidin-3-yl)acetic acid
Similarity: 0.84
[ 204688-60-8 ]
(R)-2-(1-Boc-3-pyrrolidinyl)acetic Acid
Similarity: 0.84
[ 1441673-92-2 ]
Potassium (S)-5-(tert-butoxycarbonyl)-5-azaspiro[2.4]heptane-6-carboxylate
Similarity: 0.98
[ 1352882-80-4 ]
2-(tert-Butoxycarbonyl)-2-azaspiro[5.5]undecane-9-carboxylic acid
Similarity: 0.78
[ 871727-05-8 ]
6-(tert-Butoxycarbonyl)-6-azaspiro[2.5]octane-1-carboxylic acid
Similarity: 0.78
[ 1357354-49-4 ]
2-tert-Butyl 9-ethyl 2,7-diazaspiro[4.4]nonane-2,9-dicarboxylate
Similarity: 0.74